Risk factors associated with the co-occurrence of severe pain and sleep disturbance in oncology outpatients receiving chemotherapy
A significant proportion of patients receiving chemotherapy experience the co-occurrence of severe pain and sleep disturbance. Oncology clinicians need to work with primary care providers to optimize the management of these two symptoms.
Authors
- Yvette P. Conley (ORCID: https://orcid.org/0000-0002-1784-6067)
- Astrid Block
- Sueann Mark
- Alison B. Peattie
- Bruce A. Cooper (ORCID: https://orcid.org/0000-0001-8932-4113)
- Jon D. Levine
- Steven M. Paul
- Marilyn J Hammer
- Christine Miaskowski
- Frances Cartwright
Institutions
- University of Pittsburgh (US)
- University of California, San Francisco (US)
- Mount Sinai Medical Center (US)
- Dana-Farber Cancer Institute (US)
Publication Details
- Journal
- Supportive Care in Cancer
- Published
- 2025-11-19
- DOI
- https://doi.org/10.1007/s00520-025-10151-2
- Primary Topic
- Pain Management and Opioid Use
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Cancer Institute